Works matching B-cell maturation antigen (BCMA)

Results: 330
    1

    CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond.

    Published in:
    Vaccines, 2023, v. 11, n. 11, p. 1721, doi. 10.3390/vaccines11111721
    By:
    • Mishra, Abhinava K.;
    • Gupta, Ashna;
    • Dagar, Gunjan;
    • Das, Dayasagar;
    • Chakraborty, Abhijit;
    • Haque, Shabirul;
    • Prasad, Chandra Prakash;
    • Singh, Archana;
    • Bhat, Ajaz A.;
    • Macha, Muzafar A.;
    • Benali, Moez;
    • Saini, Kamal S.;
    • Previs, Rebecca Ann;
    • Saini, Deepak;
    • Saha, Dwaipayan;
    • Dutta, Preyangsee;
    • Bhatnagar, Aseem Rai;
    • Darswal, Mrinalini;
    • Shankar, Abhishek;
    • Singh, Mayank
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    OAB-026: MagnetisMM-1 study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA) targeted CD3-engaging bispecific molecule, for patients (pts) with relapsed or refractory multiple myeloma (MM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S17, doi. 10.1016/S2152-2650(21)02100-5
    By:
    • Dholaria, Bhagirathbhai;
    • Bahlis, Nizar;
    • Raje, Noopur;
    • Costello, Caitlin;
    • Solh, Melhem;
    • Levy, Moshe;
    • Tomasson, Michael;
    • Dube, Harman;
    • Damore, Michael;
    • Hoi Kei Lon;
    • Basu, Cynthia;
    • Skoura, Athanasia;
    • Chan, Edward;
    • Trudel, Suzanne;
    • Jakubowiak, Andrzej;
    • Chu, Michael;
    • Gasparetto, Cristina;
    • Dalovisio, Andrew;
    • Sebag, Michael;
    • Lesokhin, Alexander
    Publication type:
    Article
    10

    MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S439, doi. 10.1016/S2152-2650(21)01978-9
    By:
    • Levy, Moshe;
    • Bahlis, Nizar;
    • Raje, Noopur;
    • Costello, Caitlin;
    • Dholaria, Bhagirathbhai;
    • Solh, Melhem;
    • Tomasson, Michael;
    • Dube, Harman;
    • Damore, Michael;
    • Hoi Kei Lon;
    • Basu, Cynthia;
    • Skoura, Athanasia;
    • Chan, Edward;
    • Trudel, Suzanne;
    • Jakubowiak, Andrzej;
    • Chu, Michael;
    • Gasparetto, Cristina;
    • Dalovisio, Andrew;
    • Sebag, Michael;
    • Lesokhin, Alexander
    Publication type:
    Article
    11

    MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S422, doi. 10.1016/S2152-2650(21)01946-7
    By:
    • Usmani, Saad Z.;
    • Berdeja, Jesus G.;
    • Madduri, Deepu;
    • Jakubowiak, Andrzej;
    • Agha, Mounzer;
    • Cohen, Adam D.;
    • Hari, Parameswaran;
    • Yeh, Tzu-Min;
    • Olyslager, Yunsi;
    • Banerjee, Arnob;
    • Jackson, Carolyn C;
    • Allred, Alicia;
    • Zudaire, Enrique;
    • Deraedt, William;
    • Wu, Xiaoling;
    • Carrasco-Alfonso, Marlene J.;
    • Akram, Muhammad;
    • Lin, Yi;
    • Martin, Thomas;
    • Jagannath, Sundar
    Publication type:
    Article
    12

    Poster: MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01578-0
    By:
    • Levy, Moshe;
    • Bahlis, Nizar;
    • Raje, Noopur;
    • Costello, Caitlin;
    • Dholaria, Bhagirathbhai;
    • Solh, Melhem;
    • Tomasson, Michael;
    • Dube, Harman;
    • Damore, Michael;
    • Lon, Hoi Kei;
    • Basu, Cynthia;
    • Skoura, Athanasia;
    • Chan, Edward;
    • Trudel, Suzanne;
    • Jakubowiak, Andrzej;
    • Chu, Michael;
    • Gasparetto, Cristina;
    • Dalovisio, Andrew;
    • Sebag, Michael;
    • Lesokhin, Alexander
    Publication type:
    Article
    13

    Poster: MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S249, doi. 10.1016/S2152-2650(21)01569-X
    By:
    • Usmani, Saad Z.;
    • Berdeja, Jesus G.;
    • Madduri, Deepu;
    • Jakubowiak, Andrzej;
    • Agha, Mounzer;
    • Cohen, Adam D.;
    • Hari, Parameswaran;
    • Yeh, Tzu-Min;
    • Olyslager, Yunsi;
    • Banerjee, Arnob;
    • Jackson, Carolyn C;
    • Allred, Alicia;
    • Zudaire, Enrique;
    • Deraedt, William;
    • Wu, Xiaoling;
    • Carrasco-Alfonso, Marlene J.;
    • Akram, Muhammad;
    • Lin, Yi;
    • Martin, Thomas;
    • Jagannath, Sundar
    Publication type:
    Article
    14

    Oral Abstract: MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01275-1
    By:
    • Usmani, Saad Z.;
    • Berdeja, Jesus G.;
    • Madduri, Deepu;
    • Jakubowiak, Andrzej;
    • Agha, Mounzer;
    • Cohen, Adam D.;
    • Hari, Parameswaran;
    • Yeh, Tzu-Min;
    • Olyslager, Yunsi;
    • Banerjee, Arnob;
    • Jackson, Carolyn C;
    • Allred, Alicia;
    • Zudaire, Enrique;
    • Deraedt, William;
    • Wu, Xiaoling;
    • Carrasco-Alfonso, Marlene J.;
    • Akram, Muhammad;
    • Yi Lin;
    • Martin, Thomas;
    • Jagannath, Sundar
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22

    In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1394, doi. 10.3390/ijms25031394
    By:
    • Jiang, Genqiao;
    • Neuber, Brigitte;
    • Hückelhoven-Krauss, Angela;
    • Höpken, Uta E.;
    • Ding, Yuntian;
    • Sedloev, David;
    • Wang, Lei;
    • Reichman, Avinoam;
    • Eberhardt, Franziska;
    • Wermke, Martin;
    • Rehm, Armin;
    • Müller-Tidow, Carsten;
    • Schmitt, Anita;
    • Schmitt, Michael
    Publication type:
    Article
    23
    24
    25

    Les anticorps bispécifiques.

    Published in:
    Hematologie, 2021, v. 27, p. 19, doi. 10.1684/hma.2021.1650
    By:
    • Le Grand, Sophie;
    • Perrot, Aurore
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Cellular Therapies for Multiple Myeloma: Engineering Hope.

    Published in:
    Cancers, 2024, v. 16, n. 22, p. 3867, doi. 10.3390/cancers16223867
    By:
    • Vera-Cruz, Sarah;
    • Jornet Culubret, Maria;
    • Konetzki, Verena;
    • Alb, Miriam;
    • Friedel, Sabrina R.;
    • Hudecek, Michael;
    • Einsele, Hermann;
    • Danhof, Sophia;
    • Scheller, Lukas
    Publication type:
    Article
    35
    36

    Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 734, p. 1, doi. 10.1126/scitranslmed.adg7962
    By:
    • Díez-Alonso, Laura;
    • Falgas, Aïda;
    • Arroyo-Ródenas, Javier;
    • Romencín, Paola A.;
    • Martínez, Alba;
    • Gómez-Rosel, Marina;
    • Blanco, Belén;
    • Jiménez-Reinoso, Anaïs;
    • Mayado, Andrea;
    • Pérez-Pons, Alba;
    • Aguilar-Sopeña, Óscar;
    • Ramírez-Fernández, Ángel;
    • Segura-Tudela, Alejandro;
    • Perez-Amill, Lorena;
    • Tapia-Galisteo, Antonio;
    • Domínguez-Alonso, Carmen;
    • Rubio-Pérez, Laura;
    • Jara, Maria;
    • Solé, Francesc;
    • Hangiu, Oana
    Publication type:
    Article
    37

    Deciphering the genetics and mechanisms of predisposition to multiple myeloma.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50932-7
    By:
    • Went, Molly;
    • Duran-Lozano, Laura;
    • Halldorsson, Gisli H.;
    • Gunnell, Andrea;
    • Ugidos-Damboriena, Nerea;
    • Law, Philip;
    • Ekdahl, Ludvig;
    • Sud, Amit;
    • Thorleifsson, Gudmar;
    • Thodberg, Malte;
    • Olafsdottir, Thorunn;
    • Lamarca-Arrizabalaga, Antton;
    • Cafaro, Caterina;
    • Niroula, Abhishek;
    • Ajore, Ram;
    • Lopez de Lapuente Portilla, Aitzkoa;
    • Ali, Zain;
    • Pertesi, Maroulio;
    • Goldschmidt, Hartmut;
    • Stefansdottir, Lilja
    Publication type:
    Article
    38
    39
    40

    Early Cytomegalovirus Reactivation in Renal Recipients Is Associated with High Levels of B Cell Maturation Antigen Transcript Expression Prior to Transplantation.

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10491, doi. 10.3390/ijms241310491
    By:
    • Alfaro, Rafael;
    • Rodríguez-Aguilar, Luis;
    • Llorente, Santiago;
    • Jimenez-Coll, Victor;
    • Martínez-Banaclocha, Helios;
    • Galián, José Antonio;
    • Botella, Carmen;
    • Moya-Quiles, María Rosa;
    • Muro-Perez, Manuel;
    • Minguela, Alfredo;
    • Legaz, Isabel;
    • Muro, Manuel
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50